Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Successful rescue therapy with the anti-CD19 antibody tafasitamab in anti-MDA5-positive interstitial lung disease suggests therapeutic effects of conventional anti-CD19 antibodies.

Annals of the rheumatic diseases·2026
Same author

The burden of steroid use in systemic lupus erythematosus.

Rheumatology (Oxford, England)·2026
Same author

Interdisciplinary Clinical Practice Guidelines for patient-centred management of juvenile-onset systemic lupus erythematosus.

EULAR rheumatology open·2026
Same author

Belimumab induces early and sustained resolution of lupus thrombocytopenia.

Lupus science & medicine·2026
Same author

Zeitschrift fur Rheumatologie·2026
Same author

Beyond screening for pulmonary arterial hypertension: The DETECT score is a potential promising prediction tool for all-cause mortality in systemic sclerosis: Analysis from the EUSTAR database.

Journal of autoimmunity·2026

Related Experiment Video

Updated: Dec 13, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.4K

Inflammatory markers in systemic lupus erythematosus.

Martin Aringer1

  • 1University Medical Center and Faculty of Medicine Carl Gustav Carus at the TU Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.

Journal of Autoimmunity
|December 9, 2019
PubMed
Summary

Current inflammation markers for systemic lupus erythematosus (SLE) are limited. Novel urinary T cell analysis shows potential for improved monitoring of renal inflammation in SLE patients.

Keywords:
AnemiaC-reactive proteinChemokinesCytokinesSystemic lupus erythematosus

More Related Videos

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
12:36

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on: June 26, 2018

9.8K
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.4K

Related Experiment Videos

Last Updated: Dec 13, 2025

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.4K
Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry
12:36

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on: June 26, 2018

9.8K
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.4K

Area of Science:

  • Immunology
  • Nephrology
  • Rheumatology

Background:

  • Systemic lupus erythematosus (SLE) is characterized by autoantibodies and immune complexes, leading to inflammatory organ manifestations.
  • Current SLE activity assessments rely heavily on organ inflammation, but routine laboratory markers have limited impact.
  • Existing markers like erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and procalcitonin (PCT) are often non-specific or inadequate for accurately gauging SLE activity.

Purpose of the Study:

  • To evaluate the limitations of current laboratory markers for assessing SLE inflammatory activity.
  • To explore the potential of novel biomarkers, including cytokines, chemokines, and urinary cellular elements, for improved SLE monitoring.
  • To investigate the utility of urinary T cell analysis for better monitoring of renal inflammation in SLE.

Main Methods:

  • Review of existing literature on laboratory markers for SLE inflammation.
  • Analysis of the utility of serum-based inflammatory markers (ESR, CRP, PCT, cytokines, chemokines).
  • Assessment of urinary markers, including proteinuria, cytokines, chemokines, and cellular elements, with a focus on T cells.

Main Results:

  • Routine markers like ESR, CRP, and PCT have limited utility in reflecting SLE disease activity.
  • While some cytokines (interferons, IL-18, TNF) and chemokines correlate with SLE activity, their routine measurement is challenging.
  • Urinary analysis, particularly of T cells, shows promise for monitoring renal inflammation, despite current routine laboratory limitations.

Conclusions:

  • Existing serum inflammatory markers are insufficient for comprehensive SLE activity assessment.
  • Novel biomarkers, including specific cytokines and chemokines, show potential but require further validation for routine clinical use.
  • Urinary T cell analysis presents a promising avenue for more accurate and timely monitoring of renal inflammation in SLE.